**Short answer: no, not on this evidence.** The top-ranked pairs score well on this benchmark, but the data suggest the predictor is mostly recognising which proteins tend to interact, not predicting pair-specific interactions. That is the wrong skill for nominating new drug targets.

**What I checked**
- `scores.tsv` has 858 scored pairs, all of which match `labels.tsv`. The labels file has 52,725 pairs, so only 1.6% of them were scored.
- The scored pairs are 60% positive, against a 9% positive rate in the full labels. The 858 were therefore not a random sample.
- The scored pairs involve 612 proteins with a median of 16 labelled pairs each, against 6 for proteins overall. They lean toward well-studied, highly connected proteins.

**Headline performance looks excellent**
- AUROC is 0.944 and AUPRC is 0.960. The AUPRC baseline is 0.60, since 60% of the scored pairs are positive.
- Precision at the top is 100% for the top 10, 25 and 50, and 98.5% for the top 200.

**Why I don't trust it**
1. **A baseline that ignores the pair does as well.** I scored each pair using only how often its two proteins are positive in the rest of the labels. That excludes the pair's own label (leave-one-out). It gets AUROC 0.955, slightly above the predictor's 0.944.
2. **Within the high-confidence pairs the predictor is weak.** For the 374 pairs scoring above 0.1, its AUROC is 0.64. The protein-identity baseline gets 0.89 on the same pairs. A rank of 0.99 versus 0.80 therefore carries little real information.
3. **The score tracks protein identity.** It correlates at 0.54 with the leave-one-out protein positive rate. The top-100 pairs reuse the same proteins, with one protein appearing in 10 of them.
4. **The scores look like two groups.** 484 pairs sit at a floor of about 0.004, with only 176 distinct values among them. Of those, 32% are true interactions, so the predictor misses about a third of them. It does separate them somewhat (AUROC 0.86), but I think that mostly reflects protein identity.
5. **I can't tell how pairs were chosen for scoring, and the benchmark may leak.** If the same proteins appear in training and test, a predictor can score well without learning interactions. Labels may also be biased toward well-studied proteins. I can't check either from these files.

**What the top-pair precision does and doesn't tell you**
- The 98.5% top-200 precision comes from a set that is 60% positive and made of hub proteins. In the full benchmark about 9% of pairs are positive, and a realistic screen would be sparser still.
- Recovering known interactions among well-studied proteins is not the same as nominating novel targets. Hub proteins are also the least attractive drug targets, because interfering with them is likely to be toxic.

**Recommendation**
- Don't use the top-ranked pairs for target nomination yet.
- Re-evaluate on a split where test proteins are unseen in training (a cold-protein split) and the scored pairs are drawn at random.
- Compare against the protein-identity baseline above, and require the predictor to beat it clearly.
- Score the full labelled set and report precision at the realistic positive rate.
- Add orthogonal evidence before acting on any nominated pair, such as expression, structure or experimental validation.

I ran the checks in `a.py` and `b.py` in the scratchpad directory.
